Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.
Identifieur interne : 001D51 ( Ncbi/Curation ); précédent : 001D50; suivant : 001D52Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.
Auteurs : Richard M. Trosch [États-Unis] ; Charles H. Adler ; Eric J. PappertSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2007.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-Dyskinesia Agents, Botulinum Toxins.
- drug therapy : Hemifacial Spasm.
- Adult, Aged, Dose-Response Relationship, Drug, Drug Evaluation, Female, Humans, Male, Middle Aged, Pain Measurement, Time Factors, Treatment Outcome.
Abstract
Evaluate the safety of botulinum toxin type B (BoNT-B) in subjects with hemifacial spasm (HFS).
DOI: 10.1002/mds.21435
PubMed: 17588242
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002608
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002608
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002938
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001D51
Links to Exploration step
pubmed:17588242Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.</title>
<author><name sortKey="Trosch, Richard M" sort="Trosch, Richard M" uniqKey="Trosch R" first="Richard M" last="Trosch">Richard M. Trosch</name>
<affiliation wicri:level="2"><nlm:affiliation>The Parkinson's Disease and Movement Disorders Center, 26400 W, Southfield, Michigan, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Disease and Movement Disorders Center, 26400 W, Southfield, Michigan</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H" last="Adler">Charles H. Adler</name>
</author>
<author><name sortKey="Pappert, Eric J" sort="Pappert, Eric J" uniqKey="Pappert E" first="Eric J" last="Pappert">Eric J. Pappert</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21435</idno>
<idno type="RBID">pubmed:17588242</idno>
<idno type="pmid">17588242</idno>
<idno type="wicri:Area/PubMed/Corpus">002608</idno>
<idno type="wicri:Area/PubMed/Curation">002608</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002938</idno>
<idno type="wicri:Area/Ncbi/Merge">001D51</idno>
<idno type="wicri:Area/Ncbi/Curation">001D51</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.</title>
<author><name sortKey="Trosch, Richard M" sort="Trosch, Richard M" uniqKey="Trosch R" first="Richard M" last="Trosch">Richard M. Trosch</name>
<affiliation wicri:level="2"><nlm:affiliation>The Parkinson's Disease and Movement Disorders Center, 26400 W, Southfield, Michigan, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Parkinson's Disease and Movement Disorders Center, 26400 W, Southfield, Michigan</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H" last="Adler">Charles H. Adler</name>
</author>
<author><name sortKey="Pappert, Eric J" sort="Pappert, Eric J" uniqKey="Pappert E" first="Eric J" last="Pappert">Eric J. Pappert</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Botulinum Toxins (therapeutic use)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Evaluation</term>
<term>Female</term>
<term>Hemifacial Spasm (drug therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pain Measurement</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hemifacial Spasm</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pain Measurement</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Evaluate the safety of botulinum toxin type B (BoNT-B) in subjects with hemifacial spasm (HFS).</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001D51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:17588242 |texte= Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:17588242" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |